Introduction to the <i>RSC Advances</i> themed collection on nanotubes: fabrication, properties, and applications
Durante O., Di Bartolomeo A.
Laboratory Study, published in RSC Adv (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- RSC Adv (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40365214
- PMCID
- PMC12070470
- DOI
- 10.1039/d5ra90046h
Abstract (original English)
Ofelia Durante and Antonio Di Bartolomeo introduce the RSC Advances themed issue on nanotubes: fabrication, properties, and applications.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.